Three Pathways of Cancer Cachexia: Inflammation, Changes in Adipose Tissue and Loss of Muscle Mass—The Role of miRNAs

According to the World Health Organization, in 2018, cancers, along with over 18 million new cases and over 9.5 million deaths remained one of the main causes of mortality globally. Cancer-cachexia, also called wasting syndrome is a complex, multifactorial disorder characterized by progressive skele...

Full description

Bibliographic Details
Main Authors: Iwona Homa-Mlak, Dominika Pigoń-Zając, Paweł Wawrejko, Teresa Małecka-Massalska, Radosław Mlak
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Journal of Personalized Medicine
Subjects:
Online Access:https://www.mdpi.com/2075-4426/12/9/1438
_version_ 1797486073189761024
author Iwona Homa-Mlak
Dominika Pigoń-Zając
Paweł Wawrejko
Teresa Małecka-Massalska
Radosław Mlak
author_facet Iwona Homa-Mlak
Dominika Pigoń-Zając
Paweł Wawrejko
Teresa Małecka-Massalska
Radosław Mlak
author_sort Iwona Homa-Mlak
collection DOAJ
description According to the World Health Organization, in 2018, cancers, along with over 18 million new cases and over 9.5 million deaths remained one of the main causes of mortality globally. Cancer-cachexia, also called wasting syndrome is a complex, multifactorial disorder characterized by progressive skeletal muscle mass loss, with or without adipose tissue atrophy. It is considered as a state of cancer-related malnutrition (CRM) accompanied by inflammation, that is irreversible despite the introduction of nutritional support. Indication of markers of pre-cachectic state seems to be urgently needed. Moreover, such markers have also potential to be used in the assessment of the effects of anti-cachexia treatment, and prognosis. miRNAs are non-coding RNA molecules that are about 20–30 nucleotides long. Single miRNA has the potential to control from few dozen to several hundred different genes. Despite the fact, that the number of miRNAs keep growing. we are making steady progress in establishing regulatory targets and their physiological levels. In this review we described the current knowledge on the impact of miRNAs on processes involved in cancer cachexia development: inflammation, adipose tissue remodelling, and loss of muscle mass both in animal models and the human cohorts. The available studies suggest that miRNAs, due to their properties, e.g., the possibility of regulating even hundreds of different genes, signalling pathways, and biological processes by one molecule, but also due their stability in biological material, the fact, that the change in their level reflects the disease status or the response to the applied treatment, they have great potential to be used as valuable biomarkers in the diagnosis, treatment, and prognosis of cancer cachexia.
first_indexed 2024-03-09T23:28:59Z
format Article
id doaj.art-21136d07f5a64fa7b7514360715d9321
institution Directory Open Access Journal
issn 2075-4426
language English
last_indexed 2024-03-09T23:28:59Z
publishDate 2022-08-01
publisher MDPI AG
record_format Article
series Journal of Personalized Medicine
spelling doaj.art-21136d07f5a64fa7b7514360715d93212023-11-23T17:13:08ZengMDPI AGJournal of Personalized Medicine2075-44262022-08-01129143810.3390/jpm12091438Three Pathways of Cancer Cachexia: Inflammation, Changes in Adipose Tissue and Loss of Muscle Mass—The Role of miRNAsIwona Homa-Mlak0Dominika Pigoń-Zając1Paweł Wawrejko2Teresa Małecka-Massalska3Radosław Mlak4Department of Human Physiology, Medical University of Lublin, Radziwiłłowska 11, 20-080 Lublin, PolandDepartment of Human Physiology, Medical University of Lublin, Radziwiłłowska 11, 20-080 Lublin, PolandDepartment of Nursing Education, Johns Hopkins University School of Nursing, Wolfe Street, Baltimore, MD 21205, USADepartment of Human Physiology, Medical University of Lublin, Radziwiłłowska 11, 20-080 Lublin, PolandDepartment of Human Physiology, Medical University of Lublin, Radziwiłłowska 11, 20-080 Lublin, PolandAccording to the World Health Organization, in 2018, cancers, along with over 18 million new cases and over 9.5 million deaths remained one of the main causes of mortality globally. Cancer-cachexia, also called wasting syndrome is a complex, multifactorial disorder characterized by progressive skeletal muscle mass loss, with or without adipose tissue atrophy. It is considered as a state of cancer-related malnutrition (CRM) accompanied by inflammation, that is irreversible despite the introduction of nutritional support. Indication of markers of pre-cachectic state seems to be urgently needed. Moreover, such markers have also potential to be used in the assessment of the effects of anti-cachexia treatment, and prognosis. miRNAs are non-coding RNA molecules that are about 20–30 nucleotides long. Single miRNA has the potential to control from few dozen to several hundred different genes. Despite the fact, that the number of miRNAs keep growing. we are making steady progress in establishing regulatory targets and their physiological levels. In this review we described the current knowledge on the impact of miRNAs on processes involved in cancer cachexia development: inflammation, adipose tissue remodelling, and loss of muscle mass both in animal models and the human cohorts. The available studies suggest that miRNAs, due to their properties, e.g., the possibility of regulating even hundreds of different genes, signalling pathways, and biological processes by one molecule, but also due their stability in biological material, the fact, that the change in their level reflects the disease status or the response to the applied treatment, they have great potential to be used as valuable biomarkers in the diagnosis, treatment, and prognosis of cancer cachexia.https://www.mdpi.com/2075-4426/12/9/1438miRNAcancer cachexiainflammationbrowning of white adipose tissuemuscle atrophy
spellingShingle Iwona Homa-Mlak
Dominika Pigoń-Zając
Paweł Wawrejko
Teresa Małecka-Massalska
Radosław Mlak
Three Pathways of Cancer Cachexia: Inflammation, Changes in Adipose Tissue and Loss of Muscle Mass—The Role of miRNAs
Journal of Personalized Medicine
miRNA
cancer cachexia
inflammation
browning of white adipose tissue
muscle atrophy
title Three Pathways of Cancer Cachexia: Inflammation, Changes in Adipose Tissue and Loss of Muscle Mass—The Role of miRNAs
title_full Three Pathways of Cancer Cachexia: Inflammation, Changes in Adipose Tissue and Loss of Muscle Mass—The Role of miRNAs
title_fullStr Three Pathways of Cancer Cachexia: Inflammation, Changes in Adipose Tissue and Loss of Muscle Mass—The Role of miRNAs
title_full_unstemmed Three Pathways of Cancer Cachexia: Inflammation, Changes in Adipose Tissue and Loss of Muscle Mass—The Role of miRNAs
title_short Three Pathways of Cancer Cachexia: Inflammation, Changes in Adipose Tissue and Loss of Muscle Mass—The Role of miRNAs
title_sort three pathways of cancer cachexia inflammation changes in adipose tissue and loss of muscle mass the role of mirnas
topic miRNA
cancer cachexia
inflammation
browning of white adipose tissue
muscle atrophy
url https://www.mdpi.com/2075-4426/12/9/1438
work_keys_str_mv AT iwonahomamlak threepathwaysofcancercachexiainflammationchangesinadiposetissueandlossofmusclemasstheroleofmirnas
AT dominikapigonzajac threepathwaysofcancercachexiainflammationchangesinadiposetissueandlossofmusclemasstheroleofmirnas
AT pawełwawrejko threepathwaysofcancercachexiainflammationchangesinadiposetissueandlossofmusclemasstheroleofmirnas
AT teresamałeckamassalska threepathwaysofcancercachexiainflammationchangesinadiposetissueandlossofmusclemasstheroleofmirnas
AT radosławmlak threepathwaysofcancercachexiainflammationchangesinadiposetissueandlossofmusclemasstheroleofmirnas